In prostate cancer cells, LPA receptor 1 (LPAR1) expression was sufficient to allow LPA-initiated migration and co-expression of CD97 and LPAR1 resulted in enhanced Rho-dependent invasion relative to LPAR1 alone [16]. The gene discussed is LPAR1; the disease is prostate carcinoma.